From December 9 to 12, researchers and physicians from NYU Langone Health join colleagues from around the world at the 2025 San Antonio Breast Cancer Symposium in San Antonio, Texas.
Below are notable sessions featuring our faculty and trainees. For a full list of presentations, visit the SABCS website.
Tuesday, December 9
Workshop
Utilizing liquid biopsy for detection and monitoring CNS metastases
Session: Translational Workshop 2: Liquid Biopsy in Breast Cancer, Bridging Technology and Clinical Practice
NYU Langone Presenter: Alexandra M. Miller, MD
Time: 12:45–2:15PM
Location: Stars at Night 3-4
Wednesday, December 10
Poster
Acupuncture for Preventing Progression of Taxane-Induced Peripheral Neuropathy (ATP) Beyond Cryotherapy: A Phase II Randomized, Double-Blinded, Sham-Controlled Trial
Session: Poster Session 1
NYU Langone Presenter: Iris Zhi, MD, PhD
Time: 12:30–2:00PM
Location: Exhibit Hall
Poster
Physical activity level differences among Non-Hispanic White and Chinese American breast cancer survivors
Session: Poster Session 1
NYU Langone Presenter: Maryann Kwa, MD
Time: 12:30–2:00PM
Location: Exhibit Hall
Poster
Real-world utilization of tissue-free ctDNA monitoring in patients with breast cancer
Session: Poster Session 2
NYU Langone Presenter: Douglas K. Marks, MD
Time: 5:00–6:30PM
Location: Exhibit Hall
Thursday, December 11
Poster
Is Breast Cancer After Kidney Transplant More Common in Men?
Session: Poster Session 3
NYU Langone Presenter: Matthew Sporn, MD
Time: 12:30–2:00PM
Location: Exhibit Hall
Oral Presentation
PIK3R1 (p85α) alterations define a targetable subset of breast cancer with broad sensitivity to PI3K and AKT inhibitors
Session: Rapid Fire 4
NYU Langone Presenter: Shalinda Fernando, PhD
NYU Langone Author: Neil Vasan, MD, PhD
Time: 4:30–5:30PM
Location: Stars at Night 1-2
Poster
Oncotype DX prediction of recurrence by race
Session: Poster Session 4
NYU Langone Author: Naomi Y. Ko, MD, MPH
Time: 5:00–6:30PM
Location: Exhibit Hall
Friday, December 12
Poster
I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant vepdegestrant monotherapy or in combination with letrozole or abemaciclib in molecularly selected patients with Stage 2/3 HR+ HER2-negative breast cancer (BC)
Session: Poster Spotlight 10: Novel Combinations with Endocrine Therapy
NYU Langone Author: Nancy Chan, MD
Time: 7:00–8:30AM
Location: 301 ABC
Poster
Pathologic complete response rates (pCR) after the novel HER2 ADC ARX788 in the neoadjuvant setting: Results from the I-SPY2.2 trial
Session: Rapid Fire 5
NYU Langone Author: Nancy Chan, MD
Time: 12:30–1:30PM
Location: Stars at Night 1-2
Poster
Novel Targeting of the Microenvironment to Decrease Metastatic Recurrence of High-Risk TNBC: A Randomized Phase 2 Study of Tetrathiomolybdate (TM), an oral copper depletion agent plus capecitabine +/- pembrolizumab in patients with breast cancer at high risk of recurrence (NCT06134375)
Session: Poster Session 5
NYU Langone Author: Nancy Chan, MD
Time: 12:30–2:00PM
Location: Exhibit Hall
Oral Presentation
Understanding treatment-related hair loss, emerging therapies, and access to care
Session: Beyond Cancer: Addressing Body Image, Hair Loss, and Skin Health After Treatment
NYU Langone Presenter: Mario Lacouture, MD
Time: 1:00–2:50PM
Location: 221 ABC
